Skip to main content
Clinical Trials/CTRI/2020/12/029554
CTRI/2020/12/029554
Not yet recruiting
未知

A prospective observational study to identify and evaluate the adverse drug reactions among patients on anti-tubercular medications

TEP RNTCP OR three Programme Government of Karnataka0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: A15-A19- Tuberculosis
Sponsor
TEP RNTCP OR three Programme Government of Karnataka
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
TEP RNTCP OR three Programme Government of Karnataka

Eligibility Criteria

Inclusion Criteria

  • All adults with drug sensitive tuberculosis who are on anti\-tubercular treatment for 6 months will be included in the study. The total study duration is for 12 months. All eligible TB patients from the four selected TUs will be enrolled in the study.

Exclusion Criteria

  • TB patients notified by private and transferred out to other than TUs selected for the study will be excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials